Talk to me about all things drug discovery, from small molecules to biologics to cell & gene therapies

Joined June 2016
62 Photos and videos
James Hallinan retweeted
26 Sep 2024
Evotec SE announced today that Evotec has entered a technology development partnership with Novo Nordisk in cell therapy. hubs.ly/Q02RbBGz0 #TogetherForMedicinesThatMatter #CellTherapy
3
8
1,046
James Hallinan retweeted
23 Sep 2024
Join us at Booth #B20 at ELRIG Drug Discovery! Don't miss Sven Schreiter's talk on "Automated High Content Screening", Oct 3rd, 12:15 PM. And Saman Honarnejad will be co-chairing the "Advances in Assay Development and Screening" track. More details: hubs.ly/Q02QBPM10
2
2
298
James Hallinan retweeted
6 Sep 2024
Evotec at Advanced Therapies Europe (ATE)! Our VP of ATMP Global Regulatory Affairs, Michela Gabaldo, will chair a panel on: Accelerating Cell and Gene Therapy Innovation: Regulatory Pathways in Europe. Learn more: hubs.ly/Q02Nj1pp0 #ATE #Biotech #CellandGeneTherapy
3
1
492
James Hallinan retweeted
4 Sep 2024
Join the Technology Networks online symposium, Advances in Drug Discovery & Development 2024 from 18 - 19 September 2024. Our VP RNA Biology, Dr. Steffen Grimm, is presenting on "Drug Development in the RNA world".. hubs.ly/Q02NhGB00
1
2
207
James Hallinan retweeted
3 Sep 2024
We will delve into the latest advancements in microRNA research, exploring the therapeutic potential of #miRNA-targeting treatments, in our upcoming #oligonucleotide therapies webinar, "Unlocking the Potential of miRNA-Targeted Therapies". Register here- hubs.ly/Q02Nn4xZ0
1
5
309
James Hallinan retweeted
2 Sep 2024
Have you registered already? This Wednesday, we are continuing our webinar series on hit identification strategies at Evotec. Please register now for episode 4 "The Role of Structural Insights in Drug Discovery" hubs.ly/Q02NhBKt0
1
5
229
James Hallinan retweeted
20 Aug 2024
Evotec is supporting Advanced Therapies Europe #ATE24 as an Associate Sponsor, and our colleagues are representing our approach and our expertise to deliver iPSC-based cell therapeutics within various sessions. Learn more here- hubs.ly/Q02LRXJd0 #CellTherapy
1
4
353
James Hallinan retweeted
30 May 2024
Evotec announced that the Company entered a partnership with Inserm, the French National Institute of Health and Medical Research, Lille University Hospital and Inserm Transfert (the private subsidiary of Inserm). Learn more read the full press release- hubs.ly/Q02yXwF_0
1
3
9
772
James Hallinan retweeted
19 Jan 2024
Watch @JustEvotecBio's first virtual roundtable on #continuousmanufacturing of #biologics. For this session we invited @Vir_Biotech as they discuss "How real is continuous manufacturing and what are the challenges?". Stream it now - hubs.ly/Q02h0jXc0 #researchneverstops
2
5
451
James Hallinan retweeted
22 Nov 2023
Heartfelt thanks to BSTP for choosing Evotec Verona to host their annual meeting! It has been a pleasure to welcome these brilliant minds for scientific discussions about the future of cell therapy and the crucial role of pathology in this field #BSTPASM2023 #researchneverstops
1
2
385
James Hallinan retweeted
19 Oct 2023
This month, join Evotec in Brussels at the European Society of Gene and Cell Therapy conference where our experts will present a scientific poster on AAV-based vectors. Meet the team at Booth #8 | Get in touch to book a meeting - hubs.ly/Q025BdSW0 #researchneverstops
1
3
491
James Hallinan retweeted
12 Oct 2023
We're thrilled to announce our presence at #ELRIG2023 | Join us at Booth #B9 to explore the latest in drug discovery innovations. Schedule a meeting with our experts, Helen Box & James Hallinan - info@evotec.com #ELRIG2023 #DrugDiscovery #Innovation #researchneverstops
2
6
519
James Hallinan retweeted
2 Oct 2023
Evotec is excited to participate in the iPSC-Derived Cell Therapies Summit in Boston this week. Our experts will present oral and scientific poster presentations | Discover more - hubs.ly/Q023Z2fd0 #researchneverstops #iPSC #celltherapy
1
7
450
James Hallinan retweeted
27 Sep 2023
Join Evotec in Brussels next month at #ESGCT23 where our experts will present on AAV-based vectors | Meet the team at booth #8 to discuss your gene and cell therapy requirements | Get in touch to book a meeting - info@evotec.com #researchneverstops
2
4
363
So of all the exciting and innovative technology and product development consultancies in Cambridge, only one seems to have made the jump to... threads.net/t/CujAYiJIqFF/?i…

102
It's #InternationalWomenInEngineeringDay - who are the women engineers that have inspired & impressed you? I'm lucky to have known @ELNSMNS and Mary Karavenglemann, both excellent biomedical engineers, and collaborated with @NeekaMashouf who is an amazing innovator @rubi_earth
76
A nice thing about living near @Cambridge_Uni is the range of seminars open to the public. Today's great presentation by Kelly Monk of @MonkLab1 at @VollumInstitute was on oligodendrocyte precursor cells, an exciting target for #genetherapy for #MultipleSclerosis @CentreMyelin
1
1
197
1st - in vivo #GeneTherapy is very cool at the best of times, and using a targeted LNP vector is a nice approach. 2nd, the vector is aimed at the asialoglycoprotein receptor (ASGP-R) which was the receptor I used for my PhD! Back then you couldn't really express it so ... 2/3
1
42
I had to use native rat ASGP-R to make my #scFv libraries - not the most fun! Finally, @VerveTx had some FDA challenges last year about tropism so my recent experience about using not just surface molecules but also direct-to-organ delivery devices is v. relevant. Well done all!
36